DexCom, Inc. (DXCM) Reports Q3 Loss of 20c, Misses by 4c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $74.96 +2.66%
EPS Growth %: +27.1%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: +27.1%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
DexCom, Inc. (NASDAQ: DXCM) reported Q3 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $18.3 million versus the consensus estimate of $19.05 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time
- WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
- PepsiCo (PEP) Misses Q2 EPS by 1c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
